Consultations on ECHA Executive Director’s requests related to the CLH process - previous consultations

The listed consultations following ECHA Executive Director's requests related to the CLH process have already taken place and have now been closed. These consultations were held to allow parties concerned to comment and to help RAC in adopting an opinion on a specific issue related to the classification and labelling of a substance following a request from ECHA's Executive Director according to Article 77(3) of REACH.

The substances are listed in the table below together with information on the subject of the ED request, the mandate given to ECHA's Committee for Risk Assessment and the documents on which the comments were requested.

There are currently no ongoing consultations.
Epoxiconazole 406-850-2 133855-98-8 23/07/2012 Details
Gallium arsenide 215-114-8 1303-00-0 19/06/2013 Details